top of page

ARVO 2026: NEXT GENERATION RETINA THERAPEUTICS AND ADVANCES IN AI SHOWCASE


Moderators: Allen C. Ho, MD and Srinivas Sadda, MD,

Panel: Mark Humayun, MD, PhD and Anat Loewenstein, MD, MHA 

Room: 405

Start
Company
Presenter
1:30 PM
Introduction
Srinivas Sadda, MD
1:31 PM
Ripple Therapeutics
Tom Reeves, Co-Founder, President & CEO
1:36 PM
Kanaph Therapeutics
Wai T. Wong, MD, PhD, Co-Founder, President & CEO
1:41 PM
OD-OS MacuTherm
Jan Tode, MD, Chief Medical Officer
1:46 PM
Discussion
1:51 PM
Alkeus Pharmaceuticals
Michel Dahan, President & CEO
1:56 PM
Octant
Matthew L. Albert, MD PhD, VP, Discovery Biology & Early Clinical Development
2:01 PM
Discussion
2:04 PM
Neuvasq Biotechnologies
Ralph Laufer, PhD, Chief Scientific Officer
2:09 PM
Surrozen
Daniel L. Chao, MD, PhD, VP, Head of Clinical Development
2:14 PM
Oculis
Riad Sherif, MD, CEO
2:19 PM
Discussion
Anchor 1
bottom of page